Metabolic manifestations of polycystic ovary syndrome in nonobese adolescents: Retinol-binding protein 4 and ectopic fat deposition

Fertility and Sterility

Volumn 97, Issue 4, 2012, Pages 1009-1015

  Sopher, Aviva B ^a   Gerken, Adrienne T ^a   Blaner, William S ^a   Root, Jeremy M ^a   McMahon, Donald J ^a   Oberfield, Sharon E ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

insulin resistance; intrahepatic lipid; Polycystic ovary syndrome; retinol binding protein 4; triglycerides

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL BINDING PROTEIN 4; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY FAT; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; DYSLIPIDEMIA; ECTOPIC FAT DEPOSITION; ECTOPIC TISSUE; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID COMPOSITION; LIPID LIVER LEVEL; LIPID STORAGE; METABOLIC DISORDER; MUSCLE CELL; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOGENESIS; ADOLESCENT; AGE FACTORS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HORMONES; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; RETINOL-BINDING PROTEINS, PLASMA; TRIGLYCERIDES; YOUNG ADULT;

EID: 84859158673     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.01.111     Document Type: Article

References (45)

1. R.J. Norman, D. Dewilly, R.S. Legro, and T.E. Hickey Polycystic ovarian syndrome Lancet 370 2008 685 697
2. R. Azziz, E. Carmina, D. Dewilly, E. Diamanti-Kandarakis, H.F. Excobar-Morreal, and W. Futterweit The Androgen Excess and PCOS Society criteria for polycystic ovary syndrome: the complete task force report Fertil Steril 912 2009 456 488
3. T. Chan, Y. Tsai, P. Chiu, Y. Chen, C. Lee, and E. Tsai Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome Fertil Steril 93 2010 869 873
4. K.M. Korenblat, E. Fabbrini, B.S. Mohammed, and S. Klein Liver, muscle and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects Gastroenterology 134 2008 1369 1375
5. Y. Tamori, H. Sakaue, and M. Kasuga RBP-4, an unexpected adipokine Nat Med 12 2006 30 31
6. Q. Yang, T.E. Graham, N. Mody, F. Preitner, O.D. Peroni, and J.M. Zabolotny Serum retinol-binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature 436 2005 356 362
7. T.E. Graham, Q. Yang, M. Bluher, A. Hammarstedt, T.P. Ciaraldi, and R.R. Henry Retinol-binding protein 4 and insulin resistance in lean, obese and diabetic subjects N Engl J Med 354 2006 2552 2563
8. N. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, and E. Schleicher High circulating retinol-binding protein 4 is associate with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans Diabetes Care 30 2007 1173 1178
9. E. Fabbrini, F. Magkos, B.S. Mohammed, T. Pietka, N.A. Abumarad, and B.W. Patterson Intrahepatic fat, not visceral fat is linked with metabolic complications of obesity Proc Natl Acad Sci 106 2009 15430 15435
10. I. Aebreli, R. Biebenger, R. Lehmann, D. L'Allemand, G.A. Spinas, and M.B. Zimmermann Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children J. Clin Endocrinol Metab 92 2007 4359 4365
11. D. Lee, J. Lee, and J. Im Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents Metabolism 56 2007 327 331
12. A.B. Sopher, A.T. Gerken, E. Lee, W.E. Blaner, S. Deeds, and D. Gallagher Retinol-binding protein 4 correlates with triglycerides but not insulin resistance in prepubertal children with and without premature adrenarche J Pediatr Endocrinol Metab 24 9-10 2011 683 687
13. P. Baglopal, T.E. Graham, B.B. Kahn, A. Altomare, V. Funanage, and D. George Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation J Clin Endocrinol Metab 92 2007 1971 1974
14. E. Goodman, T.E. Graham, L.M. Dolan, S.R. Daniels, E.R. Goodman, and B.B. Kahn The relationship retinol binding protein 4 to changes in insulin resistance and cardiometabolic risk in overweight black adolescents J Pediatr 154 2008 67 73
15. D. Yeste, J. Vendrell, R. Tomasini, L.L. Gallart, M. Clemente, and I. Simon Retinol-binding protein 4 levels in obese children and adolescents with glucose intolerance Horm Res Paediatr 73 2010 335 340
16. C. Kanaka-Gantenbein, A. Margeli, P. Pervanidou, S. Sakka, G. Mastorakos, and G.P. Chrousos Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: When children are not just "small adults." Clin Chem 54 2008 1176 1182
17. S. Hahn, M. Backhaus, M. Broecker-Preuss, S. Tan, T. Dietz, and R. Kimmig Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism Eur J Endocrinol 157 2007 201 207
18. T.M. Barber, M. Hazell, C. Christodoulides, S.J. Golding, C. Alvey, and K. Burling Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis of this condition J Clin Endocrinol Metab 93 2008 2859 2865
19. B.K. Tan, J. Chen, H. Lehnert, R. Kennedy, and H.S. Randeva Raised serum, adipocyte and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids J Clin Endocrinol Metab 92 2007 2764 2772
20. B.O. Yildiz, G. Bozdag, U. Otegan, A. Harmanci, K. Boynukalin, and Z. Vutal Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS Reprod BioMed Online 20 2010 150 155
21. S.K. Hutchinson, C. Harrison, N. Stepto, C. Meyer, and H.J. Teede Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome Diabetes Care 31 2008 1427 1432
22. R. Yildizhan, G.A. Ilham, B. Yildizhan, A. Kolusari, E. ADali, and G. Bugdayci Serum retinol-binding protein 4, leptin and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome Fertil Steril 96 2011 246 250
23. K.F. Petersen, S. Dufour, D.B. Savage, S. Bilz, G. Solomon, and S. Yonemitsu The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome Proc Natl Acad Sci 104 2007 12587 12594
24. J.D. McGarry What if Minkowski had been ageusic? An alternative angle on diabetes Science 258 1992 766 770
25. J. Despres, and I. Lemieux Abdominal obesity and metabolic syndrome Nature 444 2006 881 887
26. C. Cerda, R.M. Perez-Ayuso, A. Riquelme, A. Soza, P. Villaseca, and T. Sir-Petermann Nonalcoholic fatty liver disease in women with polycystic ovary syndrome J Hepatol 47 2007 412 417
27. M. Gambarin-Gelwan, S. Kinkhabwala, T.D. Schiano, C. Bodian, H. Yeh, and W. Futterweit Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndr Clin Gastroenterol Hepatol 5 2007 496 501
28. S.E. Barlow Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report Pediatrics 120 Suppl 4 2007 S164 S192
29. J.K. Zawadzki, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome: towards a rational approach A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam, Polycystic ovary syndrome 1992 Blackwell Scientific Boston 377 384
30. J. Armengaud, M. Charkaluk, C. Trivin, V. Tardy, G. Breat, and R. Brauner Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche J Clin Endocrinol Metab 94 2009 2835 2840
31. R.J. Kuczmarski, C.L. Ogden, L.M. Grummer-Strawn, K.M. Flegal, Z. Mei, and R. Wei 2000 CDC growth charts for the United States: methods and development Vital Health Stat 11 246 2002 1 27
32. D. Ferriman, and J.D. Gallwey Clinical assessment of body hair growth in women J Clin Endocrinol Metab 21 1961 1440 1447
33. M.E. Silfen, A.M. Manibo, D.J. McMahon, L.S. Levine, A.R. Murphy, and S.E. Oberfield Comparison of simple measures of insulin sensitivity in young girls with premature adrenarche: the fasting glucose to insulin ratio may be a simple and useful measure J Clin Endocrinol Metab 86 2001 2863 2868
34. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
35. A. Avignon, C. Boegner, D. Mariano-Goulart, C. Colette, and L. Monnier Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state Int J Obes Relat Metab Disord 23 1999 512 517
36. M. Matsuda, and R.A. DeFronzo Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1999 1462 1470
37. J.P. Le Floch, P. Escuyer, E. Baudin, D. Baudon, and L. Perlemuter Blood glucose area under the curve. Methodological aspects Diabetes Care 13 1990 172 175
38. E. Carmina, S. Bucchieri, P. Mansueto, G. Rini, M. Ferin, and R.A. Lobo Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome Fertil Steril 91 2009 1332 1335
39. L. Weiping, C. Qingfeng, M. Shikun, L. Xiurong, Q. Hua, and B. Xiaoshu Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome Endocrine 30 2006 283 287
40. E. Aigner, N. Bachofner, K. Klein, C. De Geyter, F. Hohla, and W. Patsch Retinol-binding protein 4 in polycystic ovary syndrome-association with steroid hormones and response to pioglitazone treatment J Clin Endocrinol Metab 94 2009 1229 1235
41. M. Mohlig, M.O. Weickert, E. Ghadamgahi, A.M. Arafat, J. Spranger, and A.F.H. Pfeiffer Retinol-binding protein 4 is associated with insulin resistance but appears unsuited for metabolic screening in women with polycystic ovary syndrome Eur J Endocrinol 158 2008 517 523
42. T.L. Setji, N.D. Holland, L.L. Sanders, K. Pereira, A.M. Diehl, and A.J. Brown Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome J Clin Endocrinol Metab 91 2006 1741 1747
43. A. Romanowska, D.M. Lebensztejn, E. Skiba, E. Tarasow, and M. Kaczmarski Retinol binding protein-4, a serum biomarker of intrahepatic lipid content in obese children - a preliminary report Acta Biochimica Polonica 58 2011 35 38
44. P. Kotnik, P. Fischer-Posovszky, and M. Wabitsch RBP4: a controversial adipokine Eur J Endocrinol 165 2011 703 711
45. E. Carmina, S.E. Oberfield, and R.A. Lobo The diagnosis of polycystic ovary syndrome in adolescents Am J Obstet Gynecol 203 2010 201.e1 201.e5